SCYNEXIS, Inc. Tax Withholding Paid on Stock Awards
SCYNEXIS, Inc. (SCYX) reported Tax Withholding Paid on Stock Awards of $3.00 thousand for the 9-month period ending 2021-09-30, per its 10-Q filed 2021-11-10.
Discontinued › Cash Flow › Financing Activities
us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation · last filed 2021-11-10
- SCYNEXIS, Inc. payment, tax withholding, share-based payment arrangement for the quarter ending 2021-09-30 was $3.00K, a 50.00% increase year-over-year.
- SCYNEXIS, Inc. payment, tax withholding, share-based payment arrangement for the quarter ending 2021-06-30 was -$15.00K.
- SCYNEXIS, Inc. payment, tax withholding, share-based payment arrangement for the quarter ending 2021-03-31 was $15.00K, a 79.45% decline year-over-year.
- SCYNEXIS, Inc. payment, tax withholding, share-based payment arrangement for the quarter ending 2020-12-31 was $133.00K.
- SCYNEXIS, Inc. payment, tax withholding, share-based payment arrangement for fiscal 2020 was $208.00K.
- SCYNEXIS, Inc. payment, tax withholding, share-based payment arrangement for fiscal 2019 was $0.00.
| Period end | Payment, Tax Withholding, Share-based Payment Arrangement 3 month | Payment, Tax Withholding, Share-based Payment Arrangement 6 month | Payment, Tax Withholding, Share-based Payment Arrangement 9 month | Payment, Tax Withholding, Share-based Payment Arrangement 12 month |
|---|---|---|---|---|
| 2021-09-30 | $3.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-10 | -$12.00K derived: sum of 2 quarters · filed 2021-11-10 | $3.00K 10-Q · filed 2021-11-10 | $136.00K derived: sum of 4 quarters · filed 2021-11-10 |
| 2021-06-30 | -$15.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-16 | $0.00 10-Q · filed 2021-08-16 | $133.00K derived: sum of 3 quarters · filed 2021-08-16 | $135.00K derived: sum of 4 quarters · filed 2021-11-10 |
| 2021-03-31 | $15.00K 10-Q · filed 2021-05-17 | $148.00K derived: sum of 2 quarters · filed 2021-05-17 | $150.00K derived: sum of 3 quarters · filed 2021-11-10 | $150.00K derived: sum of 4 quarters · filed 2021-11-10 |
| 2020-12-31 | $133.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-29 | $135.00K derived: sum of 2 quarters · filed 2021-11-10 | $135.00K derived: sum of 3 quarters · filed 2021-11-10 | $208.00K 10-K · filed 2021-03-29 |
| 2020-09-30 | $2.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-10 | $2.00K derived: sum of 2 quarters · filed 2021-11-10 | $75.00K 10-Q · filed 2021-11-10 | $75.00K derived: sum of 4 quarters · filed 2021-11-10 |
| 2020-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-16 | $73.00K 10-Q · filed 2021-08-16 | $73.00K derived: sum of 3 quarters · filed 2021-08-16 | $73.00K derived: sum of 4 quarters · filed 2021-08-16 |
| 2020-03-31 | $73.00K 10-Q · filed 2021-05-17 | $73.00K derived: sum of 2 quarters · filed 2021-05-17 | $73.00K derived: sum of 3 quarters · filed 2021-05-17 | $73.00K derived: sum of 4 quarters · filed 2021-05-17 |
| 2019-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-29 | $0.00 derived: sum of 2 quarters · filed 2021-03-29 | $0.00 derived: sum of 3 quarters · filed 2021-03-29 | $0.00 10-K · filed 2021-03-29 |
| 2019-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-06 | $0.00 derived: sum of 2 quarters · filed 2020-11-06 | $0.00 10-Q · filed 2020-11-06 | |
| 2019-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-10 | $0.00 10-Q · filed 2020-08-10 | ||
| 2019-03-31 | $0.00 10-Q · filed 2020-05-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PDS Biotechnology Corp (PDSB) | United States | $0.045B | |
| Grace Therapeutics, Inc. (GRCE) | $0.046B | -1.83 | |
| VERU INC. (VERU) | United States | $0.043B | -3.93 |
| Werewolf Therapeutics, Inc. (HOWL) | United States | $0.047B | |
| Kairos Pharma, LTD. (KAPA) | United States | $0.041B | |
| Dogwood Therapeutics, Inc. (DWTX) | United States | $0.049B | |
| Lite Strategy, Inc. (LITS) | United States | $0.049B | |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 | |
| Elicio Therapeutics, Inc. (ELTX) | United States | $0.049B | |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |